Bioactive Ingredients Market Projected to Offer Substantial Growth Opportunities, Reaching $78.8 Billion by 2030

 

The bioactive ingredients market size has grown strongly in recent years. It will grow from $52.14 billion in 2025 to $56.21 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to growth in functional food consumption, increasing awareness of preventive healthcare, expansion of dietary supplement markets, rising utilization of natural health ingredients, advances in extraction technologies.

The bioactive ingredients market size is expected to see strong growth in the next few years. It will grow to $78.81 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing demand for personalized nutrition solutions, rising investment in clinical nutrition research, expansion of bioactives in personal care products, growing focus on immune health, increasing regulatory approvals for novel bioactives. Major trends in the forecast period include increasing demand for functional and fortified ingredients, rising use of plant-derived bioactives, growing adoption in personalized nutrition, expansion of microbial fermentation technologies, enhanced focus on clinical-grade bioactives.

Get your free report sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10045&type=smp

What Are the Dominant Growth Drivers Impacting the Bioactive Ingredients Market Outlook?
Increasing adoption of organic and natural ingredients is expected to propel the growth of the bioactive ingredients market going forward. Ingredients that are derived from nature and manufactured without synthetic chemicals or genetically modified organisms (GMOs) are referred to as organic and natural ingredients. Customers have become more aware of the possible health benefits of natural and organic chemicals, and many products include these ingredients. Since bioactive compounds are derived from natural sources and typically marketed as organic or natural, they appeal to health-conscious clients. For instance, in April 2025, according to the Organic Trade Association, a US-based membership-based business association, in 2024, the U.S. organic market achieved total certified sales of US$71.6 billion, led by organic food sales of US$65.4 billion. Therefore, the increasing adoption of organic and natural ingredients is driving the growth of the bioactive ingredients market.

What Are the Major Segments Defining the Structure of the Bioactive Ingredients Market?
The bioactive ingredients market covered in this report is segmented –

1) By Product: Fiber, Vitamins, Omega 3 PUFA, Plant Extracts, Minerals, Carotenoids And Antioxidants, Probiotics, Other Products
2) By Source: Plant, Animal, Microbial
3) By Application: Functional Food And Beverage, Dietary Supplements, Clinical Nutrition, Personal Care, Other Applications

Subsegments:
1) By Fiber: Soluble Fiber, Insoluble Fiber
2) By Vitamins: Water-Soluble Vitamins, Fat-Soluble Vitamins
3) By Omega 3 PUFA: EPA (Eicosapentaenoic Acid), DHA (Docosahexaenoic Acid)
4) By Plant Extracts: Herbal Extracts, Phytochemicals
5) By Minerals: Macro Minerals, Trace Minerals
6) By Carotenoids And Antioxidants: Carotenoids, Polyphenols
7) By Probiotics: Lactobacillus, Bifidobacterium
8) By Other Products: Enzymes, Peptides

Which Disruptive Trends Are Reshaping the Competitive Landscape of the Bioactive Ingredients Market?
Major companies operating in the bioactive ingredients market are focusing on product innovation, such as a new line of bioactive, to meet evolving consumer demands for enhanced health benefits and diverse applications. Diana Food Bioactives specializes in natural ingredients and extracts for the food, beverage, and dietary supplement industries, promoting health and well-being. For instance, in March 2023, Symrise, a US-based food company, launched a new range of Diana food bioactives for use in beauty products. The company is broadening its selection by creating unique and innovative nutricosmetic ingredients, offering a comprehensive range of skin conditioning, anti-aging, skin brightening, and hair and nail care. These products consist of naturally derived bioactives such as collagen type I, vitamins C and A, and polyphenols sourced from different fruits.

Which Key Players Dominate the Bioactive Ingredients Market Landscape?
Major companies operating in the bioactive ingredients market are Sabinsa Corporation, Archer Daniels Midland Company (ADM), BASF SE, Cargill Incorporated, Ajinomoto Co. Inc., DuPont de Nemours Inc., Roquette Frères, Owen Biosciences Inc., Sensient Technologies, Nuritas Ltd., Kerry Group plc, Royal FrieslandCampina N.V., Chr. Hansen A/S, Neptune Wellness Solutions Inc., Evonik Industries AG, Royal DSM N.V., Ingredion Incorporated, Tate & Lyle plc, FMC Corporation, Givaudan SA, Symrise AG, International Flavors & Fragrances Inc., Ashland Global Holdings Inc., Corbion N.V., Lonza Group AG, Novozymes A/S, Bioiberica S.A., Nexira SAS, Kemin Industries Inc., Naturex S.A., Indena S.p.A., Martin Bauer Group, Frutarom Industries Ltd., RFI Ingredients LLC, FutureCeuticals Inc., Beijing Gingko Group, Nutraceutical International Corporation, Bio-Botanica Inc.

Get the detailed bioactive ingredients market report today
https://www.thebusinessresearchcompany.com/report/bioactive-ingredients-global-market-report

Which Region Is Expected to Dominate the Bioactive Ingredients Market During the Forecast Period?
North America was the largest region in the bioactive ingredients market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global bioactive ingredients market report forecast period. The regions covered in the bioactive ingredients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

#Contact Us:#
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

#Follow Us On:#
LinkedIn: https://in.linkedin.com/company/the-business-research-company 

Comments

Post a Comment

Popular posts from this blog

2025 Strategic Guide to the Drugs For Benign Prostatic hypertrophy Market – Forecasts and Business Use Cases

Image
  The drugs for benign prostatic hypertrophy market size has grown strongly in recent years. It will grow from $4.28 billion in 2024 to $4.58 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to aging population, increased awareness, advancements in drug therapies, healthcare access. The drugs for benign prostatic hypertrophy market size is expected to see strong growth in the next few years. It will grow to $5.58 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to emerging markets, new drug developments, increasing awareness and education, regulatory approvals. Major trends in the forecast period include minimally invasive treatments, personalized medicine, combination therapies, patient-centered care, telemedicine and digital health, research and development. #Download Your Free Sample PDF:# https://www.thebusinessresearchcompany.com/sample.a...
Read more

Global Antiepileptic Drugs Market Forecast Highlights Growth Outlook And Key Trends Over 2026–2030

Image
  The antiepileptic drugs market size has grown strongly in recent years. It will grow from $17.83 billion in 2025 to $18.74 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to epilepsy prevalence growth, first-generation drug reliance, hospital neurology expansion, seizure disorder awareness, generic drug penetration. The antiepileptic drugs market size is expected to see strong growth in the next few years. It will grow to $22.87 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to treatment-resistant epilepsy management, novel AED approvals, personalized neurology care, pediatric epilepsy diagnosis, long-acting formulations. Major trends in the forecast period include shift toward third-generation AEDs, growing use of combination therapy, expansion of pediatric epilepsy management, increased adoption of long-term seizure control, growth of gene...
Read more

Generative Artificial Intelligence (AI) In Telecom Market Industry Outlook Presents Revenue And CAGR Projections To 2030

Image
  The generative artificial intelligence (AI) in telecom market size has grown exponentially in recent years. It will grow from $0.73 billion in 2025 to $1.12 billion in 2026 at a compound annual growth rate (CAGR) of 53.4%. The growth in the historic period can be attributed to growing mobile subscriber base, increasing telecom data traffic, early adoption of AI in network management, rising demand for personalized customer experiences, expansion of cloud-based telecom solutions. The generative artificial intelligence (AI) in telecom market size is expected to see exponential growth in the next few years. It will grow to $6.16 billion in 2030 at a compound annual growth rate (CAGR) of 53.0%. The growth in the forecast period can be attributed to advancements in generative AI models, integration of AI with 5G and future networks, growth in edge computing for real-time analytics, adoption of AI for security and fraud prevention, expansion of AI-driven customer support solutions. M...
Read more